In November 2004, Singapore’s Health Sciences Authority (HSA) released new guidelines on Disease Awareness Campaigns (DACs). For companies who produce drugs for rare diseases, DACs are a convenient way for companies to educate the public about a disease and its various treatment... Read More
In June 2004, Singapore amended its Patent Bill in hopes of strengthening the country’s pharmaceutical patent system. The changes should improve the pharmaceutical sector by encouraging greater innovation and research in Singapore pharmaceutical industry. Specifically, the amended Bill focuses on improving three... Read More
In an effort to ensure that Singaporeans receive quality healthcare at reasonable prices, Singapore’s Ministry of Health introduced the Medical Service Package (MSP) on July 2, 2004. The MSP, which took effect in all public institutions on July 5, 2004, will allow... Read More
On April 20, 2004, Singapore Health Sciences Authority (HSA) released a draft Bill to amend Singapore Medicines Act. The Bill will improve Singapore standing in the medical industry through better protection of pharmaceutical patents. It will also help attract more research-based pharmaceutical... Read More
The Singaporean government plans to institute new laws by the middle of 2004 to regulate the sale of health supplements in the country. This decision was made in response to two deaths, one of a local actress, occurring in 2002 as a... Read More
Effective January 1, 2004, the Singapore Health Sciences Authority (HSA) launched a consolidated Center for Drug Administration (CDA). The center was formed as a result of a merger between two of HSA’s former professional centers responsible for the regulation and evaluation of... Read More
In late October 2003, Singapore’s Ministry of Health announced the drafting of a new bill that would regulate research and collection of human stem cells and tissue. The draft law called the Regulation of Biomedical Research Bill has been placed on the... Read More
Singapore’s Health Sciences Authority (HSA) and China’s State Food and Drug Administration (SFDA) recently signed a Memorandum of Understanding (MOU) formalizing their agreement to further strengthen cooperation between the two government agencies. Both agencies are responsible for regulating drugs and health-related products... Read More
The ASEAN (Association of Southeast Asian Nations) Consultative Committee for Standards and Quality (ACCSQ) was formed in 1992 by the ASEAN Economic Ministers. The purpose of the committee is to eliminate technical barriers to trade and facilitate the objectives of the ASEAN... Read More
Singapore’s Health Sciences Authority (HSA) has been developing an electronic licensing system to support the regulatory functions of the Centre for Pharmaceutical Administration (CPA) since 2001. The HSA implemented the first part of its electronic system in April 15, 2003 with the... Read More